Evolent Health Price to Free Cash Flow Ratio 2014-2025 | EVH
Historical price to free cash flow ratio values for Evolent Health (EVH) since 2014.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Evolent Health Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-07-09 | 11.29 | 0.00 | |
| 2025-03-31 | 9.47 | $-0.08 | 0.00 |
| 2024-12-31 | 11.25 | $-0.05 | 0.00 |
| 2024-09-30 | 28.28 | $0.98 | 28.85 |
| 2024-06-30 | 19.12 | $1.35 | 14.13 |
| 2024-03-31 | 32.79 | $1.18 | 27.85 |
| 2023-12-31 | 33.03 | $1.02 | 32.28 |
| 2023-09-30 | 27.23 | $0.49 | 55.24 |
| 2023-06-30 | 30.30 | $-0.06 | 0.00 |
| 2023-03-31 | 32.45 | $0.05 | 703.90 |
| 2022-12-31 | 28.08 | $-0.53 | 0.00 |
| 2022-09-30 | 35.93 | $-0.06 | 0.00 |
| 2022-06-30 | 30.71 | $0.46 | 66.91 |
| 2022-03-31 | 32.30 | $0.06 | 520.13 |
| 2021-12-31 | 27.67 | $0.16 | 173.05 |
| 2021-09-30 | 31.00 | $-0.75 | 0.00 |
| 2021-06-30 | 21.12 | $-1.52 | 0.00 |
| 2021-03-31 | 20.20 | $-0.85 | 0.00 |
| 2020-12-31 | 16.03 | $-0.54 | 0.00 |
| 2020-09-30 | 12.41 | $-0.29 | 0.00 |
| 2020-06-30 | 7.12 | $-0.26 | 0.00 |
| 2020-03-31 | 5.43 | $-0.84 | 0.00 |
| 2019-12-31 | 9.05 | $-0.95 | 0.00 |
| 2019-09-30 | 7.19 | $-1.44 | 0.00 |
| 2019-06-30 | 7.95 | $-0.98 | 0.00 |
| 2019-03-31 | 12.58 | $-0.77 | 0.00 |
| 2018-12-31 | 19.95 | $-0.78 | 0.00 |
| 2018-09-30 | 28.40 | $-0.40 | 0.00 |
| 2018-06-30 | 21.05 | $-0.52 | 0.00 |
| 2018-03-31 | 14.25 | $-0.55 | 0.00 |
| 2017-12-31 | 12.30 | $-0.87 | 0.00 |
| 2017-09-30 | 17.80 | $-1.34 | 0.00 |
| 2017-06-30 | 25.35 | $-1.29 | 0.00 |
| 2017-03-31 | 22.30 | $-1.34 | 0.00 |
| 2016-12-31 | 14.80 | $-1.13 | 0.00 |
| 2016-09-30 | 24.62 | $-0.74 | 0.00 |
| 2016-06-30 | 19.20 | $-1.04 | 0.00 |
| 2016-03-31 | 10.56 | $-1.11 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.383B | $2.555B |
| Evolent Health, Inc. is involved in the healthcare delivery and payment markets. The company provides technology-enabled services platform for providers to transition their organization in value-based payment models. Evolent Health, Inc. is based in Arlington, Virginia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.858B | 58.34 |
| Doximity (DOCS) | United States | $11.546B | 53.45 |
| Hims & Hers Health (HIMS) | United States | $10.959B | 113.86 |
| Tempus AI (TEM) | United States | $10.129B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.298B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.936B | 61.50 |
| Hinge Health (HNGE) | United States | $3.363B | 0.00 |
| Privia Health (PRVA) | United States | $2.624B | 179.33 |
| Enovis (ENOV) | United States | $1.984B | 11.06 |
| Phreesia (PHR) | United States | $1.691B | 0.00 |
| Schrodinger (SDGR) | United States | $1.572B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.552B | 0.00 |
| Azenta (AZTA) | United States | $1.534B | 71.30 |
| 10x Genomics (TXG) | United States | $1.508B | 0.00 |
| Omnicell (OMCL) | United States | $1.389B | 24.51 |
| Claritev (CTEV) | United States | $0.815B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.594B | 0.00 |
| Standard BioTools (LAB) | United States | $0.494B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.477B | 0.00 |
| Talkspace (TALK) | United States | $0.457B | 136.50 |
| Veradigm (MDRX) | United States | $0.456B | 0.00 |
| Outset Medical (OM) | United States | $0.370B | 0.00 |
| TruBridge (TBRG) | United States | $0.345B | 766.33 |
| Health Catalyst (HCAT) | United States | $0.281B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.272B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.237B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.175B | 0.00 |
| American Well (AMWL) | United States | $0.133B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.124B | 0.00 |
| Pulmonx (LUNG) | United States | $0.110B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.103B | 0.00 |
| CareCloud (CCLD) | United States | $0.102B | 3.90 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.083B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.081B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.074B | 0.00 |
| 111 (YI) | China | $0.063B | 0.00 |
| HeartBeam (BEAT) | United States | $0.045B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.044B | 0.00 |
| Zhongchao (ZCMD) | China | $0.031B | 0.00 |
| Precipio (PRPO) | United States | $0.024B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |